Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)
Clinical trial NCT05177926 · UNKNOWN
Trial details
- NCT number
- NCT05177926
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-04
- Primary completion
- 2023-12-31
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.